Neudle.com: tenecteplase

Neurology Specific Literature Search

Differential
(Click to cross reference)

advances in neurology

adverse drug reaction

Alberta Stroke Program Early CT score

alcohol, neurologic complications with

alexia with agraphia

Alzheimer's disease

Alzheimer's disease, early onset

Alzheimer's disease, treatment of

Alzheimer's disease, visual variant

amyloid angiopathy, cerebral

amyloid beta protein

amyloid-related imaging abnormalities

aneurysm, intracranial

aneurysm, multiple intracranial

angioedema, tongue

angiography, cerebral

angioneurotic edema

angiotensin-converting enzyme, inhibitors

anterior cerebral artery

anterior cerebral artery territory infarction

anterior cerebral artery, emboli to

anterior choroidal artery

anterior spinal artery

anterior spinal artery infarction

anterior temporal branch of posterior cerebral artery

anticoagulant, complications of

anticoagulant, reversal of

anticoagulant, treatment

anticoagulant, treatment in CVD

anticoagulant, treatment, combined

antiphospholipid antibodies

arterial dissection

arterial dissection, aorta

arterial dissection, basilar

arterial dissection, carotid

arterial dissection, recurrent

arterial dissection, vertebral

arteriovenous malformation

arteriovenous malformation, cerebral

arteriovenous malformation, cerebral, ruptured

arteriovenous malformation, pulmonary

aspirin, rectal

atrial fibrillation

automobile accidents

bacterial endocarditis, neurologic manifestations of

Balint's syndrome

basilar artery occlusion

basilar artery plaque

basilar artery stenosis

biologic markers

biotinidase deficiency

bleeding disorder

blood pressure after stroke

blood pressure, asymmetric

blood transfusion

body temperature

brainstem, infarction of

brainstem, ischemia

brainstem, syndrome

calcium antagonist

cancer, cerebrovascular accident complicating patients with

cardiac surgery

cardiac tamponade

carotid angiogram

carotid artery atherosclerosis

carotid artery disease

carotid artery disease, medical management

carotid artery occlusion, intracranial

carotid artery occlusion, neck

carotid artery occlusion, recurrent

carotid artery stenosis

carotid artery stenosis, preocclusive

carotid artery stenosis, recurrent

carotid artery stenosis, tandem

carotid artery, intraluminal clot

CAT scan, abdomen

CAT scan, abnormal

CAT scan, angiography

CAT scan, angiography, source images

CAT scan, attenuation coefficient

CAT scan, cerebrovascular disease

CAT scan, chest

CAT scan, contrast enhanced

CAT scan, dense artery sign

CAT scan, dense artery sign, disappearing

CAT scan, early changes in CVA

CAT scan, false negative

CAT scan, fluid-blood level

CAT scan, helical

CAT scan, mass effect on

CAT scan, mismatch between cerebral blood volume/flow

CAT scan, mismatch between perfusion/diffusion

CAT scan, net water uptake

CAT scan, pelvis

CAT scan, perfusion

CAT scan, venography

cavernous hemangioma

central artery of Percheron

central retinal artery occlusion

cerebellar hemorrhage

cerebellar infarction

cerebral arteries

cerebral embolism

cerebral embolism, cardiac origin

cerebral embolism, mechanical extraction

cerebral infarction

cerebral infarction, hemorrhagic

cerebral infarction, small, deep

cerebral ischemia

cerebral vasculature

cerebral venous infarction

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebral venous thrombosis, etiology

cerebral venous thrombosis, recurrent

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, age of lesion

cerebrovascular accident, anticoagulant treatment

cerebrovascular accident, arterial occlusion, location

cerebrovascular accident, awakening with

cerebrovascular accident, bilateral

cerebrovascular accident, cardiac disease causing

cerebrovascular accident, circadian rhythm

cerebrovascular accident, classification

cerebrovascular accident, clinical diagnosis

cerebrovascular accident, complications with

cerebrovascular accident, cost of

cerebrovascular accident, delay in presentation

cerebrovascular accident, delay in treatment

cerebrovascular accident, etiology

cerebrovascular accident, infancy and childhood

cerebrovascular accident, in-hospital

cerebrovascular accident, large ischemic core

cerebrovascular accident, migraine causing

cerebrovascular accident, mimics

cerebrovascular accident, minor

cerebrovascular accident, misdiagnosis

cerebrovascular accident, multiple

cerebrovascular accident, nontreatment of

cerebrovascular accident, pathophysiology

cerebrovascular accident, postoperative

cerebrovascular accident, prehospital treatment

cerebrovascular accident, prevention of

cerebrovascular accident, prognosis in

cerebrovascular accident, racial differences

cerebrovascular accident, recurrent

cerebrovascular accident, rehabilitation of

cerebrovascular accident, seizure with

cerebrovascular accident, severity

cerebrovascular accident, silent

cerebrovascular accident, spontaneous improvement after

cerebrovascular accident, stuttering

cerebrovascular accident, surgical treatment of

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, thromobolytic agents in treatment, early dramatic recovery

cerebrovascular accident, time of onset

cerebrovascular accident, time of presentation

cerebrovascular accident, time to treatment

cerebrovascular accident, unknown time of onset

cerebrovascular accident, volume

cerebrovascular accident, women

cerebrovascular accident, work up for

cerebrovascular accident, young adult

cerebrovascular disease

cerebrovascular disease, noninvasive evaluation of

cerebrovascular disease, risk factors in

cerebrovascular disease, surgical treatment of

cerebrovascular disease, treatment of

cherry red spot

circadian rhythm

clinical mismatch

Clinical Pathologic Conference(C.P.C.)

collateral circulation

Community hospital

computers, handheld

computers, medicine and

computers, neurologic diagnosis and

conflict of interest

contraindications

contrast agents, neurotoxicity of

controversies in neurology

conversion reaction

coronary artery bypass

coronary thrombolysis

cortical infarction, small

cost effectiveness

coumarin, stopping treatment

craniectomy, decompressive

C-reactive protein, elevated

creatinine, elevated

critical care unit

critical pathway

cryoprecipitate

DAWN stroke trial

decision analysis

delay in diagnosis

dementia, treatment of

denial of blindness(Antons syndrome)

dense middle cerebral artery sign

dense posterior cerebral artery sign

diabetes mellitus

diagnosis related group

diagnostic criteria

disability rating scale, neurological

disability, neurological

door to needle time

doppler, transcranial

downward deviation of eyes

drug abuse, neurologic complications of

duplex ultrasound

dural sinus thrombosis

embolism, paradoxical

embolism, vertebral-basilar artery

emergencies, medical

emergencies, neurologic

emergencies, ocular

emergency medical technicians

emergency physician

emergency room, treatment of stroke

endarterectomy, carotid

endarterectomy, carotid-complications of

endarterectomy, carotid-indications for

endarterectomy, carotid-timing after stroke

endocarditis, acute bacterial

endocarditis, infectious

endocarditis, neurologic manifestations with

endocarditis, subacute bacterial

endovascular therapy

endovascular therapy, late time window

endovascular therapy, time window

epidemiology of neurology

epistaxis, recurrent

ethics in neurology

evidence-based research

external carotid artery, disease

Factor V Leiden

factor Xa inhibitor

failed medical management

fibrinogen depleting agents

fibrinolytic agents

fibrinolytic agents, repeated use

fibrinolytic agents, combined IA and IV

fibrinolytic agents, complications

fibrinolytic agents, contraindications

fibrinolytic agents, deterioration following

fibrinolytic agents, discontinuation

fibrinolytic agents, exclusion criteria

fibrinolytic agents, intra-arterial local infusion

fibrinolytic agents, intra-venous local infusion

fibrinolytic agents, utilization

fibrinolytic therapy, prehospital treatment

fibrinolytic therapy, selection criteria

fibrinolytic therapy, timing of administration

fibroblast growth factor

fresh frozen plasma

gammaglobulin therapy, intravenous

gastrointestinal bleeding

genetic counselling

genetic testing

Gerstmann syndrome

give-way weakness

glioblastoma multiforme(astrocytoma Gr.III)

glomerular filtration rate

glucose level, serum

headache, severe

heart valve surgery

hematoma, intracerebral

hemianopia, homonymous

hemispherectomy

hemoglobin abnormality, neurologic complications of

hemopericardium

hemorrhagic diathesis

hemosiderosis of CNS, superficial

hemostatic therapy

hereditary hemorrhagic telangiectasia(HHT)

herniation syndromes, intracranial

hip abductor sign

hippocampal infarction

hospital length of stay

Howell-Jolly bodies

hyperbilirubinemia

hyperintense vessel sign

hypotension, systemic

iatrogenic neurologic disorders

informed consent

institutional review board

internal carotid artery

interobserver agreement

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intracerebral hemorrhage, location of

intracerebral hemorrhage, multiple

intracerebral hemorrhage, progression of

intracerebral hemorrhage, small

intracerebral hemorrhage, treatment of

intracerebral hemorrhage, volume

intracranial hemorrhage

intracranial pressure, increased

intraventricular hemorrhage

intraventricular hemorrhage, clot evacuation

intraventricular hemorrhage, primary

intraventricular hemorrhage, treatment

ischemic penumbra

lactic dehydrogenase(LDH)

lacunar infarction

lacunar infarction, differential diagnosis of

left handedness

left-right orientation

leg weakness, unilateral

level of consciousness

level of consciousness, decreased

level of consciousness, fluctuating

life expectancy

malformation, vascular

malformation, vascular, cerebral

malformation, vascular, treatment of

Marcus Gunn pupil

medical-legal aspects of neurology

medullary streaks

medullary veins

memory, defect of recent

memory, impairment of

microhemorrhage, intracerebral

middle cerebral artery

middle cerebral artery territory infarction

middle cerebral artery territory infarction, malignant

middle cerebral artery, branch occlusion

middle cerebral artery, emboli to

middle cerebral artery, occlusion of

middle cerebral artery, stenosis of

Monkeypox infection

monoclonal antibodies

moyamoya, adult

MR WITNESS trial

MRI, angiography

MRI, angiography, contrast enhanced

MRI, CAT scan compared to

MRI, cerebrovascular disease

MRI, contrast enhanced

MRI, diffusion weighted

MRI, diffusion weighted, negative

MRI, diffusion weighted, reversal

MRI, disappearing lesion on

MRI, early changes in CVA

MRI, false negative

MRI, field strength

MRI, FLAIR, hyperintense vessels

MRI, flow void, blood

MRI, gradient-echo

MRI, mismatch between DWI/FLAIR

MRI, mismatch between perfusion/diffusion

MRI, spinal cord

MRI, susceptibility weighted

MRI, venography

multimodal neuroimaging

myocardial infarction

myocardial infarction, acute

myocardial injury

neoplasm, intracranial-incidence and epidemiology of

neoplasm, primary intracerebral

neoplasm, primary of CNS

neoplasm, primary of CNS-hemorrhage in

neuritis, causes of

neurohospitalist

neurologic complications of, surgery

neurologic complications of, systemic disease

neurologic consultation

neurologic disease, diagnoses of

neurologic education

neurologic examination, focal

neurologic practice

neurologic recovery

neurologic signs

neurologic symptoms

neurology residency

neuroprotective agents

neuroradiology, interventional

NIH stroke scale

NIH stroke scale, fluctuating

NMDA antagonists

non-vitamin K antagonist oral anticoagulants

number needed to treat

occipital lobe, infarction

old age, neurology of

optic neuropathy

oral contraceptives

outcome research

pain, abdominal

partial thromboplastin time

partial thromboplastin time, prolonged

patent foramen ovale

patient information and support

patient selection

peripheral blood smear, abnormal

physician-patient relationship

platelet inhibiting drugs

platelet inhibiting drugs, combined

platelet transfusion

posterior cerebral artery

posterior cerebral artery embolism

posterior cerebral artery occlusion

posterior cerebral artery territory infarction

posterior cerebral artery, fetal type

posterior circulation stroke

postoperative neurologic complications

practice guidelines

pregnancy, neurologic complications in

prethrombotic state

prevention of neurologic disorders

protein C deficiency

protein S deficiency

prothrombin time

protocol violations

quality assurance

quality of care

quality of life

radial pulse, unilateral decrease of

RAPID CT perfusion maps

recanalization, arterial

recanalization, venous

recombinant activated factor VII

rehabilitation for neurologic disorders

reocclusion, cerebral artery

repetitive nerve stimulation

retinal ischemia

Retriever Device

REVASCAT trials

revascularization, surgical

risk-benefit assessment

sickle cell crisis

sickle cell disease

single photon emission computed tomography

solitaire device

sonothrombolysis

speech disorder

spinal cord, infarction of

spinal cord, ischemic lesion of

stent, basilar artery

stent, basilar artery, efficacy

stent, carotid artery

stent, vertebral artery

stereotaxic surgery

steroid therapy, CNS treatment and complications with

stool, guaiac positive

stroke disability scale

stroke protocol

stroke protocol, activation

stroke unit, mobile

stroke, progression of

strokelike episodes

subarachnoid hemorrhage

subarachnoid hemorrhage, treatment of

subdural hematoma

superior sagittal sinus thrombosis

SWIFT PRIME Trials

T lesion of MCA-ICA

target red cells

telephone, cellular

thalamus, infarction of

thrombectomy, distal occlusion

thrombolysis, mechanical

thrombus, intracardiac

tissue plasminogen activator, intravenous

Todd's paralysis

tongue, swelling

transient ischemic attack

transient ischemic attack, treatment of

transluminal angioplasty, basilar artery

transluminal angioplasty, intracranial

transluminal angioplasty, intracranial-indications for

transluminal angioplasty, vertebral artery

transport of patient

treatment delay

treatment of neurologic disorder

ultrasonography

ultrasonography, carotid artery

ultrasonography, head

uncal herniation

unconsciousness

unconsciousness, transient

urinary incontinence

vertebral artery

vertebral artery occlusion

vertebral artery stenosis

vertebral-basilar artery, atherosclerosis

vertebral-basilar artery, intraluminal clot

vertebral-basilar insufficiency

vestibular function, tests of

visual acuity, decreased, monocular

visual field defect

visual impairment

visual loss, sudden

visual loss, sudden-unilateral

weakness, functional

Showing articles 400 to 450 of 472 << Previous Next >>

Combined Intravenous and Intra-Arterial r-TPA Versus Intra-Arterial Therapy of Acute Ischemic Stroke, Emergency Management of Stroke (EMS) Bridging Trial
Stroke 30:2598-2605, Lewandowski,C.A.,et al, 1999

Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999

Randomised Double-Blind Placebo-Controlled Trial of Thrombolytic Therapy with Intravenous Alteplase in Acute Ischaemic Stroke (ECASS II)
Lancet 352:1245-1251,1238, Hacke,W.,et al, 1998

Thrombolysis with Intravenous rtPA in a Series of 100 Cases of Acute Carotid Territory Stroke,Determination of Etiological,Topographic,and Radiological Outcome Factors
Stroke 29:2529-2540, Trouillas,P.,et al, 1998

Alteplase Not Yet Proven for Acute Ischaemic Stroke
Lancet 352:1238-1239,1245, Bath,P., 1998

Risk for Intracranial Hemorrhage after Tissue Plasminogen Activator Treatment for Acute Myocardial Infarction
Ann Int Med 129:597-604, Gurwitz,J.H.,et al, 1998

Thrombolysis-Related Intracranial Hemorrhage, Analysis of 224 Cases from GUSTO-1 Trial with Clin Correl
Stroke 29:563-569, Gebel,J.M.,et al, 1998

Thrombolytic Therapy in Acute Stroke
Arch Neurol 55:155-157, Horowitz,S.H., 1998

Early Intravenous Thrombolysis with Recombinant Tissue-Type Plasminogen Activator in Vertebrobasilar Ischemic Stroke
Arch Neurol 55:466-469, 4501998., Grond,M.,et al, 1998

Early Intravenous Thrombolysis for Acute Ischemic Stroke in a Community-Based Approach
Stroke 29:1544-1549, Grond,M.,et al, 1998

Treating Ischemic Stroke as an Emergency
Arch Neurol 55:457-461, Adams,H.P., 1998

Cranial CT Interpret in Acute Stroke, Physician Accuracy in Determ Elig for Thrombolytic Therapy
JAMA 279:1293-1297, 13071998., Schriger,D.L.,et al, 1998

Role of CT Angiography in Patient Selection for Thrombolytic Therapy in Acute Hemispheric Stroke
Stroke 29:935-938, Wildermuth,S.,et al, 1998

Cost-Effectiveness of Tissue Plasminogen Activator for Acute Ischemic Stroke
Neurol 50:883-890, Fagan,S.C.,et al, 1998

Hemopericardium and Cardiac Tamponade after Thrombolysis for Acute Ischemic Stroke
Neurol 50:1857-1859, Kasner,S.E.,et al, 1998

Neurologists'Attitudes Regading rt-PA for Acute Ischemic Stroke
Neurol 50:1491-1494, Villar-Cordova,C.,et al, 1998

Further Evolution Toward Effective Therapy for Acute Ischemic Stroke
JAMA 279:1298-1303, 13041998., Fisher,M.&Bogousslavsky,J., 1998

tPA-Associated Reperfusion After Acute Stroke Demonstrated by SPECT
Stroke 29:429-432, Grotta,G.J.&Alexandrov,A.V., 1998

I. V. t-PA for Acute Ischemic Stroke, Feasibility, Safety & Efficacy in the First Year of Clinical Practice
Stroke 29:18-22, Chiu,D.,et al, 1998

Generalized Efficacy of t-PA for Acute Stroke
The NINDS t-PA Stroke Study Group, Stroke 28:2119-21251997., , 1997

Should Thrombolytic Therapy be the First-Line Treatment for Acute Ischemic Stroke
NEJM 337:1309-1313, Caplan,L.R.,et al, 1997

When is Thrombolysis Justified in Patients with Acute Stroke? A Bioethical Perspective
Stroke 28:214-218, Furlan,A.J.&Kanoti,G., 1997

Direct Endovascular Thrombolytic Therapy for Dural Sinus Thrombosis:Infusion of Alteplase
AJNR 18:639-645, Kim,S.Y.&Suh,J.H., 1997

A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997

Ischemic Cerebral Infarction After rt-PA and Heparin Therapy for Acute Myocardial Infarction
Stroke 28:1107-1114, Sloan,M.A.,et al, 1997

Brain SPECT with HMPAO & Safety of Thrombolytic Therapy in Acute Ischemic Stroke
Stroke 28:1830-1834, Alexandrov,A.V.,et al, 1997

Hemorrhagic Transformation in Acute Ischemic Stroke
Stroke 28:957-960, Larrue,V.,et al, 1997

Intravenous Thrombolysis for Acute Stroke
Neurol 49:14-29, Lyden,P.D.,et al, 1997

Systematic Review of Evidence on Thrombolytic Therapy for Acute Ischaemic Stroke
Lancet 350:607-614, Wardlaw,J.M.,et al, 1997

A Systems Approach to Immediate Evaluation and Management of Hyperacute Stroke
NINDS Stroke Study Group, Stroke 28:1530-15401997., , 1997

Acute Stroke:Usefulness of Early CT Findings Before Thrombolytic Therapy
Radiology 205:327-333, von Kummer,R.,et al, 1997

Total Quality Improvement Method for Reduct of Delays Between ER Dept Adm & Trtm of Acute Ischemic Stroke
Arch Neurol 54:1466-1474, Tilley,B.C.,et al, 1997

Prethrombolysis Brain Imaging:Trends and Controversies
AJNR 18:1830-1834, Castillo,M., 1997

Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic Stroke
The NINDS t-PA Stroke Study Group, Stroke 28:2109-21181997., , 1997

Tissue-Type Plasminogen Activator Should Not be Used in Acute Ischemic Stroke
Arch Neurol 53:1306-1308, Riggs,J.E., 1996

Thrombolysis for Stroke
Arch Neurol 53:1305-1306, 13081996., Brott,T., 1996

TPA Within 3 Hours of Acute Ischaemic Stroke
Lancet 348:1600-1601, Dorman,P.&Sandercock,P., 1996

Prognostic Value of the Hyperdense Middle Cerebral Artery Sign and Stroke Scale Score Before Ultraearly Thrombolytic Therapy
AJNR 17:79-85, Tomsick,T.,et al, 1996

Open Trial of I. V. Tissue Plasminogen Activator in Acute Carotid Territory Stroke-Correl of Outcome with Clin & Radiol Data
Stroke 27:882-890, Trouillas,P.,et al, 1996

Thrombolytic Therapy for Acute Ischemic Stroke-Summary Statement
Report of the Quality Standards Subcommittee of the AAN, Neurol 47:835-8391996., , 1996

Thrombolysis in Acute Stroke, Defining Risk to Benefit Ratio
BMJ 313:640-641, Bogousslavsky,J., 1996

Thrombolytic Treatment for Acute Occlusion of the Basilar Artery
JNNP 58:227-228, Huemer,M.,et al, 1995

Clin Features & Pathog of Intracerebral Hemorrhage after rt-PA & Heparin Therapy for Acute Myocardial Infarct
Neurol 45:649-658, Sloan,M.A.,et al, 1995

Intraventricular Recombinant Tissue Plasminogen Acivator for Lysis of Intraventricular Haemorrhage
JNNP 58:447-451, Rohde,V.,et al, 1995

Thrombolytic Therapy in Acute Occlusion of the Intracranial Internal Carotid Artery Bifurcation
AJNR 16:1977-1986, 19941995., Jansen,O.,et al, 1995

Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Acute Hemispheric Stroke:The ECASS
JAMA 274:1017-1025, 10581995., Hacke,W.,et al, 1995

Tissue Plasminogen Activator for Acute Ischemic Stroke
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, NEJM 333:1581-1587, 12,1995., 1995

Evaluation of Risk of Hemorrhagic Transformation in Local Intra-arterial Thrombolysis in Acute Ischemic Stroke by Initial SPECT
Stroke 25:298-303, Ueda,T.,et al, 1994

Factors Related to Intracranial Hematoma in Pts Receiving Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
Stroke 25:291-297, Levy,D.E.,et al, 1994

Prospective Study of Endogenous Tissue Plasminogen Activator and Risk of Stroke
Lancet 343:940-943, Ridker,P.M.,et al, 1994

Showing articles 400 to 450 of 472 << Previous Next >>